Isebenza ngokukhethekile kuma-Peptides

Iminyaka Engamashumi Amabili Yokuzinikezela:

Kusukela ekunyatheleni kwethu okuphansi, kuvula uhambo oluhle kakhulu.

010203

Izigaba Zomkhiqizo

Umkhiqizo Oyinhloko

01020304

Mayelana

Inkampani Hybio Pharmaceutical Co., Ltd.

Yasungulwa ngo-1998, i-Hybio iyinkampani ehamba phambili yama-peptide e-China egxile ekuthuthukisweni, ekukhiqizeni nasekudayiseni ama-peptide okwelapha i-API nezidakamizwa ezisekelwe ku-peptide, ezisohlwini lwemakethe ezinekhodi yesitoko engu-300199.

Ngokuhlangenwe nakho kweminyaka engaphezu kwengu-20, i-Hybio inikeza uhla oluphelele lwemikhiqizo nezinsizakalo zokwenziwa ze-peptide, kanye ne-CRO ne-CDMO yocwaningo, ukuthuthukiswa komtholampilo kanye nezicelo zezentengiselwano zezinkampani ezenza imithi emhlabeni wonke. Imikhiqizo eyinhloko isetshenziswe ekwelapheni izifo zokugaya ukudla, izifo ze-cardio-cerebro-vascular, isifo sikashukela, izifo ezithathelwanayo, umdlavuza, kanye nezifo ze-senile, njll.

Buka okwengeziwe

isisombululo sethu

Sikunikeza

I-Peptide eyenziwe ngokwezifiso

Sisebenzisa ubuchwepheshe bethu bama-peptide, kanye nenkundla yethu eqinile ye-R&D, thina kwa-Hybio sinikeza ama-peptide angokwezifiso anobunzima obuhlukahlukene. Lokhu kuhlanganiswe kusetshenziswa izinqubo zesigaba esiqinile kanye nesigaba soketshezi ukuze kuhlangatshezwane nezidingo ezihlukahlukene zamakhasimende ethu omhlaba.

Buka okwengeziwe

I-CRO&CDMO

Sinikeza uhla olugcwele lwama-peptide emhlabeni jikelele, njenge-Liraglutide, i-Semaglutide ne-Exenatide yesifo sikashukela; I-Terlipressin, i-Desmopressin ne-Linaclotide ye-digestive tract kanye nesistimu ye-metabolic; I-Ganirelix, i-Cetrorelix ne-Atosiban yezokwelapha kanye ne-gynecology, njll.

Buka okwengeziwe

UBUHLE BETHU

Ukuncintisana kwethu okungumongo

ngo-2011, i-Hybio yafakwa ohlwini lwe-Shenzhen Stock Exchange Market (ikhodi yesitoko 300199), futhi yaba yibhizinisi lokuqala elifakwe ohlwini lokukhiqiza izidakamizwa ze-peptide eChina.

Buka okwengeziwe